Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors

Eilean Therapeutics · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
advanced solid tumor cancer, metastatic solid tumor, ze94-0605, selective cdk2 inhibitor, ccne1 amplification, cyclin e1, first-in-human, dose escalation, dose optimization, recommended phase 2 dose, project optimus, brain-penetrant cdk2 inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1047833
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.